Distribution of retinopathy lesions.

*defined as the presence of microaneurysms or dot-blot hemorrhages excluding individuals with self-report of diabetes or fasting blood glucose ≥126 mg/dL [7.0 mmol/L]) and individuals with secondary causes of retinopathy (e.g. branch or central retinal vein occlusions, late age-related macular degeneration) and other retinopathy phenotypes including exudates without microaneurysms or dot-blot hemorrhages and pre-retinal or vitreous hemorrhages. RS defined diabetes as a random glucose > = 11.1 mmol/L, diabetic medication or self-reported history. HTN: Current use of blood pressure medication or systolic/diastolic blood pressure ≥140/90. AGES: Age, Gene/Environment Susceptibility-Reykjavik Study. ARIC: Atherosclerosis Risk in Communities study. BMES: Blue Mountains Eye Study. CHS: Cardiovascular Health Study. MESA: Multi-Ethnic Study of Atherosclerosis. RS: Rotterdam Study. NA: Not Available.